Abstract P114 – Table 1. Demographic and baseline measures
| No. (%) unless indicated | Switch patients n = 470 | Non‐switch patients n = 641 | Total n = 931 | ||
|---|---|---|---|---|---|
| TAF switch n = 404 | Non‐TAF switch n = 66 | Total n = 470 | |||
| Age ‐ mean (SD)a | 50 (12) | 53 (11) | 50 (12) | 51 (12) | 50 (12) |
| Malea | 349 (86%) | 49 (74%) | 398 (85%) | 375 (81%) | 773 (83%) |
| Race | |||||
| Asian | ‐ | ‐ | ‐ | 3 (1%) | 3 (0%) |
| Black a , b | 62 (15%) | 18 (27%) | 80 (17%) | 122 (26%) | 202 (22%) |
| Hispanicb | 17 (4%) | 3 (5%) | 20 (4%) | 33 (7%) | 53 (6%) |
| Whiteb | 303 (75%) | 45 (68%) | 348 (74%) | 280 (61%) | 628 (67%) |
| Other | 22 (5%) | ‐ | 22 (5%) | 23 (5%) | 45 (5%) |
| Baseline measures | |||||
| CD4 count 200 (cells/mcL)b | 14/364 (4%) | 2/59 (3%) | 16/423 (4%) | 40/389 (10%) | 56/812 (7%) |
| eGFR 90 (mL/min)b | 316/391 (81%) | 53/64 (83%) | 369/455 (81%) | 255/386 (66%) | 624/841 (74%) |
a
comparison between TAF switch and non‐TAF switch is statistically significant based on chi‐square or t‐test where appropriate.
bcomparison between switch and non‐switch is statistically significant based on chi‐square or t‐test where appropriate.